Bear bile powder attenuates senecionine-induced hepatic sinusoidal obstruction syndrome in mice

• Published in: Chinese journal of natural medicines 2022-04, Vol.20 (4), p.270-281
• Main Authors: JIANG, Kai-Yuan, ZHANG, Yi, YE, Xuan-Ling, XIONG, Fen, CHEN, Yan, JIA, Xia-Li, ZHANG, Yi-Xin, YANG, Li, XIONG, Ai-Zhen, WANG, Zheng-Tao
• Format: Article
• Language: English
• Subjects: Animals; Bear bile powder; Bile; Bile acids; Bile Acids and Salts; Endothelial Cells - metabolism; Hepatic sinusoidal obstruction syndrome; Hepatic Veno-Occlusive Disease - chemically induced; Hepatic Veno-Occlusive Disease - drug therapy; Hepatic Veno-Occlusive Disease - pathology; Inflammation - pathology; Liver Cirrhosis - chemically induced; Liver Cirrhosis - drug therapy; Liver disease; Mice; Powders; Pyrrolizidine alkaloids; Pyrrolizidine Alkaloids - adverse effects; Ursidae
• ISSN: 1875-5364; 1875-5364
• DOI: 10.1016/S1875-5364(22)60169-9

Hepatic sinusoidal obstruction syndrome (HSOS) via exposure to pyrrolizidine alkaloids (PAs) is with high mortality and there is no effective treatment in clinics. Bear bile powder (BBP) is a famous traditional animal drug for curing a variety of hepatobiliary diseases such as cholestasis, inflammation, and fibrosis. Here, we aim to evaluate the protective effect of BBP against HSOS induced by senecionine, a highly hepatotoxic PA compound. Our results showed that BBP treatment protected mice from senecionine-induced HSOS dose-dependently, which was evident by improved liver histology including reduced infiltration of inflammatory cells and collagen positive cells, alleviated intrahepatic hemorrhage and hepatic sinusoidal endothelial cells, as well as decreased conventional serum liver function indicators. In addition, BBP treatment lowered matrix metalloproteinase 9 and pyrrole-protein adducts, two well-known markers positively associated with the severity of PA-induced HSOS. Further investigation showed that BBP treatment prevents the development of liver fibrosis by decreasing transforming growth factor beta and downstream fibrotic molecules. BBP treatment also alleviated senecionine-induced liver inflammation and lowered the pro-inflammatory cytokines, in which tauroursodeoxycholic acid played an important role. What's more, BBP treatment also decreased the accumulation of hydrophobic bile acids, such as cholic acid, taurocholic acid, glycocholic acid, as well. We concluded that BBP attenuates senecionine-induced HSOS in mice by repairing the bile acids homeostasis, preventing liver fibrosis, and alleviating liver inflammation. Our present study helps to pave the way to therapeutic approaches of the treatment of PA-induced liver injury in clinics.